Treatment‐related mortality in newly diagnosed pediatric cancer: a population‐based analysis
Sign Up to like & getrecommendations! Published in 2018 at "Cancer Medicine"
DOI: 10.1002/cam4.1362
Abstract: Using a previously developed reliable and valid treatment‐related mortality (TRM) definition, our objective was to describe the proportion of children newly diagnosed with cancer experiencing TRM and to identify risk factors for TRM in a… read more here.
Keywords: related mortality; risk; newly diagnosed; cancer ... See more keywords
Treatment‐related adverse events of antibody–drug conjugates in clinical trials: A systematic review and meta‐analysis
Sign Up to like & getrecommendations! Published in 2022 at "Cancer"
DOI: 10.1002/cncr.34507
Abstract: Antibody–drug conjugates (ADCs) have complex molecular structures and have been tested in numerous clinical trials. Therefore, understanding the mechanisms of their toxicity when applied in medical practice is of high importance. read more here.
Keywords: clinical trials; drug conjugates; related adverse; treatment related ... See more keywords
Conventional 3D conformal radiotherapy and volumetric modulated arc therapy for cervical cancer: Comparison of clinical results with special consideration of the influence of patient- and treatment-related parameters
Sign Up to like & getrecommendations! Published in 2021 at "Strahlentherapie Und Onkologie"
DOI: 10.1007/s00066-021-01782-5
Abstract: Intensity-modulated radiotherapy (IMRT) for cervical cancer yields favorable results in terms of oncological outcomes, acute toxicity, and late toxicity. Limited data are available on clinical results with volumetric modulated arc therapy (VMAT). This study’s purpose… read more here.
Keywords: treatment; radiotherapy; related parameters; toxicity ... See more keywords
Ruxolitinib-based combinations in the treatment of myelofibrosis: worth looking forward to
Sign Up to like & getrecommendations! Published in 2020 at "Annals of Hematology"
DOI: 10.1007/s00277-020-04028-z
Abstract: Ruxolitinib is a targeted drug to treat myelofibrosis (MF). Ruxolitinib has significant advantages in spleen reduction and increasing 5-year overall survival (OS), and ruxolitinib-based combinations might provide more benefits than ruxolitinib monotherapy. In this review,… read more here.
Keywords: myelofibrosis; based combinations; treatment related; ruxolitinib based ... See more keywords
Spatiotemporal habitats from multiparametric physiologic MRI distinguish tumor progression from treatment-related change in post-treatment glioblastoma
Sign Up to like & getrecommendations! Published in 2021 at "European Radiology"
DOI: 10.1007/s00330-021-07718-y
Abstract: We aimed to develop multiparametric physiologic MRI-based spatial habitats and to evaluate whether temporal changes in these habitats help to distinguish tumor progression from treatment-related change in post-treatment glioblastoma. This retrospective, single-institution study included patients… read more here.
Keywords: tumor progression; progression; treatment related; related change ... See more keywords
Treatment related problems in Jordanian hemodialysis patients
Sign Up to like & getrecommendations! Published in 2021 at "International Journal of Clinical Pharmacy"
DOI: 10.1007/s11096-021-01259-6
Abstract: Background Treatment related problems are any event or circumstance involving patient treatment that actually or potentially interferes with an optimum outcome for a patient. Hemodialysis patients have on average 5–6 comorbid conditions and require 8–12… read more here.
Keywords: treatment; related problems; number; hemodialysis patients ... See more keywords
Personalized Approach to Cancer Treatment–Related Cardiomyopathy
Sign Up to like & getrecommendations! Published in 2020 at "Current Heart Failure Reports"
DOI: 10.1007/s11897-020-00453-3
Abstract: Purpose of Review Cancer treatment–related cardiotoxicity (CTRC) represents a significant cause of morbidity and mortality worldwide. The purpose of our review is to summarize the epidemiology, natural history, and pathophysiology of cardiotoxicity-related to cancer treatment.… read more here.
Keywords: personalized approach; treatment; cardiotoxicity; cancer treatment ... See more keywords
Microsurgical clipping of ruptured anterior choroidal artery aneurysms: Incidence of and risk factors for ischemic complications
Sign Up to like & getrecommendations! Published in 2020 at "Clinical Neurology and Neurosurgery"
DOI: 10.1016/j.clineuro.2020.105884
Abstract: OBJECTIVE Temporary clipping of the internal carotid artery can be required during microsurgery of a ruptured anterior choroidal artery (AchoA) aneurysm. Although it is suspected that such temporary clipping might be related to ischemic complications… read more here.
Keywords: ischemic complications; risk; related ischemic; clipping ... See more keywords
Low skeletal muscle mass is a predictor of treatment related toxicity in oncologic patients. A meta-analysis.
Sign Up to like & getrecommendations! Published in 2021 at "Clinical nutrition"
DOI: 10.1016/j.clnu.2021.08.023
Abstract: BACKGROUND & AIMS The purpose of this meta-analysis was to summarize the published data regarding associations between occurrence of severe treatment related toxicity and low skeletal muscle mass (LSMM) in oncologic patients and to perform… read more here.
Keywords: treatment; toxicity; oncologic patients; treatment related ... See more keywords
Treatment-related mortality in children with cancer: Prevalence and risk factors.
Sign Up to like & getrecommendations! Published in 2019 at "European journal of cancer"
DOI: 10.1016/j.ejca.2019.08.008
Abstract: AIM Intensive treatment regimens have contributed to a marked increase in childhood cancer survival rates. Death due to treatment-related adverse effects becomes an increasingly important area to further improve overall survival. In this study, we… read more here.
Keywords: children cancer; treatment; risk factors; cancer ... See more keywords
Treatment-related toxicity and improved outcome from immunotherapy in hepatocellular cancer: Evidence from an FDA pooled analysis of landmark clinical trials with validation from routine practice.
Sign Up to like & getrecommendations! Published in 2021 at "European journal of cancer"
DOI: 10.1016/j.ejca.2021.08.020
Abstract: PURPOSE The development of treatment-related adverse events (trAE) correlates favorably with clinical outcomes in multiple studies of patients receiving immune checkpoint inhibitors (ICI); however, this relationship is undefined in patients with hepatocellular carcinoma (HCC). PATIENTS… read more here.
Keywords: versus months; routine practice; clinical trials; cancer ... See more keywords